DELFI Diagnostics
Genomics & Genetic Testing · Diagnostic Tests & IVD

DELFI Diagnostics news and milestones

DELFI Diagnostics: 28 headlines on record, 0 headlines in the last 90 days. Its story counts 11 milestones.

Data updated Nov 17, 2026 · Back to the company report
28Headlines
0In 90 days
11Milestones

Headlines

Jun 82026
News · Clinical Lab Products
Clinical utility data showed that offering a blood-based lung cancer test increased screening participation compared with CT screening.
May 292026
News · Clinical Lab Products
The authorization from the New York State Department of Health makes the lung cancer bood test available in all 50 states.
May 282026
News · genomeweb.com
Delfi's laboratory-developed lung cancer screening test is now available nationwide while the company continues to pursue FDA approval.
May 282026
Press release · PRNewswire
/PRNewswire/ -- DELFI Diagnostics, Inc., developer of AI-powered, blood-based tests for cancer detection, today announced it has received a Clinical Laboratory...
May 282026
News · hackensackmeridianhealth.org
Learn how doctors at Hackensack Meridian Health are using a new lung cancer blood test to screen for the disease sooner and improve cancer outcomes.
May 182026
News · genomeweb.com
Access to the liquid biopsy nearly tripled lung cancer screening rates in a demonstration of the test's clinical utility.
May 132026
Press release · PRNewswire
/PRNewswire/ -- DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage cell-free DNA (cfDNA) fragmentomics for cancer detection and...
Apr 272026
Press release · PRNewswire
/PRNewswire/ -- DELFI Diagnostics, Inc., developer of innovative AI-powered blood-based tests that leverage cell-free DNA (cfDNA) fragmentomics for cancer...
May 29, 20252025
News · genomeweb.com
The team developed a tumor-independent test that is used to evaluate genome-wide cell-free DNA fragmentation profiles and repeat landscapes.
Feb 6, 20252025
News · Observer-Reporter
Lung cancer accounts for 1 in 5 cancer-related deaths in the United States. While doctors say lung cancer is often treatable if caught early, millions of Americans who should be…
Dec 13, 20242024
News · SoundCloud
Play EP 98 Susan Tousi - Stories from hlth. 2024 by Meeting You Where You're At on desktop and mobile. Play over 320 million tracks for free on SoundCloud.
Nov 8, 20242024
News · MLO Online
November is Lung Cancer Awareness Month. Lung cancer is the leading cause of cancer deaths in America. Fortunately, if lung cancer is caught early through screening, it is more...
Nov 3, 20242024
News · MedCity News
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care…
Oct 29, 20242024
Press release · PRNewswire
/PRNewswire/ -- Today, DELFI Diagnostics, Inc., developer of accessible blood-based liquid biopsy tests that deliver a new way to enhance early cancer...
Oct 29, 20242024
News · Illumina Ventures
Medical Laboratory Observer (MLO) November 8, 2024 Peter Bach, MD, Chief Medical Officer of DELFI Diagnostics discusses blood test for lung cancer detection
Oct 28, 20242024
Press release · PRNewswire
/PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced that...
Oct 23, 20242024
Press release · PRNewswire
/PRNewswire/ -- In a groundbreaking alliance announced today, the Florida Lung Health Coalition and DELFI Diagnostics, supported by RadNet, and the American...
Oct 22, 20242024
Press release · BioSpace
Illumina Ventures October 29, 2024 Spotlight on Susan Tousi CEO DELFI Diagnostics
Aug 26, 20242024
News · genomeweb.com
Delfi Diagnostics said that Thomas Russo has been appointed as CFO as the company expands into the blood-based liquid biopsy market with its FirstLook Lung cancer detection test.…
Aug 26, 20242024
Press release · PRNewswire
/PRNewswire/ -- Today, DELFI Diagnostics, Inc., developer of accessible blood-based liquid biopsy tests that deliver a new way to enhance early cancer...
Jun 21, 20242024
News · genomeweb.com
Delfi also published research this month demonstrating the DNA fragmentome test has an 84 percent sensitivity to detect cancer.
Jun 11, 20242024
Press release · PRNewswire
/PRNewswire/ -- Indigenous Pact, a leader in creating health equity for American Indians and Alaska Natives (AI/AN), and DELFI Diagnostics, Inc., a developer...
Jun 4, 20242024
Press release · PRNewswire
/PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced an...
Jun 3, 20242024
News · STAT
Delfi is focusing on a single disease - lung cancer - where the utility of screening with existing technology is not in dispute.
May 31, 20242024
News · dailynews
City of Hope has launched a program using a simple blood test to determine if someone might have lung cancer.
Jan 5, 20242024
News · STAT
Tousi is the fourth senior executive to leave Illumina since June, when CEO Francis deSouza abruptly resigned.
Oct 10, 20232023
News · Medical Device Network
The FirstLook Lung blood test by DELFI Diagnostics helps determine the likelihood of detecting lung cancer through a low-dose CT scan.
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

DELFI Diagnostics, News. Alion, Nov 17, 2026. https://alion.io/company/delfidiagnostics/news

.json · .md · CC BY-SA 4.0